Rubella Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live
Conditions:   Immunotoxicity;   Vaccine Intervention:   Biological: Measles, Mumps and Rubella Combined Vaccine, Live Sponsor:   Shanghai Institute Of Biological Products Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2021 Category: Research Source Type: clinical trials

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live
Condition:   Immunogenicity, Vaccine Intervention:   Biological: Measles, Mumps and Rubella Combined Vaccine, Live Sponsor:   Shanghai Institute Of Biological Products Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2021 Category: Research Source Type: clinical trials

Assessment of Safety and Immunogenicity of a Single Vial Presentation of R21/Matrix-M and Co-Administration With EPI Vaccines
Condition:   Malaria Interventions:   Biological: R21/Matrix-M - single vial formulation;   Biological: R21/Matrix-M - two vial formulation;   Biological: Licensed vaccine - Measles-rubella;   Biological: Licensed vaccine - Yellow fever;   Biological: Licensed vaccine - Pentavalent (diphtheria, tetanus, pertussis, hepatitis B and Hib);   Biological: Licensed vaccine - Oral Polio Vaccine (OPV) Sponsors:   University of Oxford;   Malaria Research and Training Center, Bamako, Mali Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2021 Category: Research Source Type: clinical trials